From Verify.Wiki
Jump to: navigation, search

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

QuickUpload1048 20170727120829.jpg
Type Public
Founded 1988
Headquarters New York, New York
Number of employees 51-200 employees



Top 5 Recent Tweets

October 26, 2020ProgenicsCBThink of @ProgenicsCB cord blood banking as a one-time insurance plan for your #baby at an affordable cost! Sign up…
October 26, 2020CoronaTurd@nikooshorty @DrDJMcCarthy @BusTTfraud @rossoscud @MimedxGroupie @GooglePumpDump @Pennywi35113773 @stevedoc22…
October 24, 2020MimedxGroupieIt used to be 2015. Before Progenics dumped it it was 2010! Fast Tracked in 2006! Na$$$ty Nattering NaDDer had “Se…
October 21, 2020bumblebee_ebookProgenics Pharmaceuticals Inc Risk Points versus Phillies Live Baseball 2017 Summer Walk-a-Thon
October 20, 2020CoronaTurd@GooglePumpDump @WallStreet_3 Good question! Likely less than the $3.5MM that naDDer’s boss paid Progenics for it w…

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history